These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32260072)

  • 1. TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases.
    Drescher F; Juárez P; Arellano DL; Serafín-Higuera N; Olvera-Rodriguez F; Jiménez S; Licea-Navarro AF; Fournier PG
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32260072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
    Min Y; Ren X; Vaught DB; Chen J; Donnelly E; Lynch CC; Lin PC
    Cancer Res; 2010 Apr; 70(7):2819-28. PubMed ID: 20233869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.
    Tivari S; Lu H; Dasgupta T; De Lorenzo MS; Wieder R
    Cell Commun Signal; 2018 Aug; 16(1):48. PubMed ID: 30119678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.
    Han HH; Kim BG; Lee JH; Kang S; Kim JE; Cho NH
    Endocr Relat Cancer; 2016 Aug; 23(8):609-23. PubMed ID: 27353038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of anaphase-promoting complex by p53 induces a state of dormancy in cancer cells against chemotherapeutic stress.
    Dai Y; Wang L; Tang J; Cao P; Luo Z; Sun J; Kiflu A; Sai B; Zhang M; Wang F; Li G; Xiang J
    Oncotarget; 2016 May; 7(18):25478-92. PubMed ID: 27009858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biglycan and reduced glycolysis are associated with breast cancer cell dormancy in the brain.
    Sunderland A; Williams J; Andreou T; Rippaus N; Fife C; James F; Kartika YD; Speirs V; Carr I; Droop A; Lorger M
    Front Oncol; 2023; 13():1191980. PubMed ID: 37456245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
    Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
    Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
    Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
    J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.
    Talukdar S; Bhoopathi P; Emdad L; Das S; Sarkar D; Fisher PB
    Adv Cancer Res; 2019; 141():43-84. PubMed ID: 30691685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models.
    Piao Y; Park SY; Henry V; Smith BD; Tiao N; Flynn DL; de Groot JF
    Neuro Oncol; 2016 Sep; 18(9):1230-41. PubMed ID: 26965451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
    Ono M; Kosaka N; Tominaga N; Yoshioka Y; Takeshita F; Takahashi RU; Yoshida M; Tsuda H; Tamura K; Ochiya T
    Sci Signal; 2014 Jul; 7(332):ra63. PubMed ID: 24985346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Endosteal Niche in Breast Cancer Bone Metastasis.
    Haider MT; Smit DJ; Taipaleenmäki H
    Front Oncol; 2020; 10():335. PubMed ID: 32232008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
    Meunier-Carpentier S; Dales JP; Djemli A; Garcia S; Bonnier P; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2005 Apr; 26(4):977-84. PubMed ID: 15753992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.
    Johnson RW; Finger EC; Olcina MM; Vilalta M; Aguilera T; Miao Y; Merkel AR; Johnson JR; Sterling JA; Wu JY; Giaccia AJ
    Nat Cell Biol; 2016 Oct; 18(10):1078-1089. PubMed ID: 27642788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow.
    Korah R; Boots M; Wieder R
    Cancer Res; 2004 Jul; 64(13):4514-22. PubMed ID: 15231661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy.
    Bushnell GG; Sharma D; Wilmot HC; Zheng M; Fashina TD; Hutchens CM; Osipov S; Wicha MS
    bioRxiv; 2023 Oct; ():. PubMed ID: 37873211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.
    Dales JP; Garcia S; Bonnier P; Duffaud F; Meunier-Carpentier S; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2003 Feb; 22(2):391-7. PubMed ID: 12527939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic Breast Cancer Cells Enter Into Dormant State and Express Cancer Stem Cells Phenotype Under Chronic Hypoxia.
    Carcereri de Prati A; Butturini E; Rigo A; Oppici E; Rossin M; Boriero D; Mariotto S
    J Cell Biochem; 2017 Oct; 118(10):3237-3248. PubMed ID: 28262977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation.
    Tivari S; Korah R; Lindy M; Wieder R
    J Vis Exp; 2015 Jun; (100):e52672. PubMed ID: 26168083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.